14:30:14 EDT Sat 20 Jul 2019
Enter Symbol
or Name
USA
CA



Login ID:
Password:
Save
Aptose Biosciences Inc (2)
Symbol C : APS
Shares Issued 37,775,766
Close 2019-02-25 C$ 2.53
Recent Sedar Documents

Aptose Biosciences to release 2018 results March 12

2019-02-26 08:57 ET - News Release

Mr. Greg Chow reports

APTOSE TO RELEASE FOURTH QUARTER AND YEAR END DECEMBER 31, 2018 FINANCIAL RESULTS AND HOLD CONFERENCE CALL ON MARCH 12, 2019

Aptose Biosciences Inc. will release its financial results for the quarter and year ended Dec. 31, 2018, on Tuesday, March 12, 2019, after the close of the market.

Conference call and webcast:  Tuesday, March 12, at 5 p.m. ET

Toll-free:  844-882-7834

International:  574-990-9707

Passcode:  5080748

Webcast:  available on-line

Replays available through March 19, 2019

Toll-free:  855-859-2056

Replay passcode:  8873259

The live conference call can also be accessed through a link on the investor relations section of Aptose's website. Please log onto the webcast at least 10 minutes prior to the start of the call to ensure time for any software downloads that may be required. An archived version of the webcast along with a transcript will be available on the company's website for 30 days.

The press release, the financial statements, and the management's discussion and analysis for the quarter ended and year ended Dec. 31, 2018, will be available on SEDAR and EDGAR.

About Aptose Biosciences Inc.

Aptose Biosciences is a clinical-stage biotechnology company committed to developing personalized therapies addressing unmet medical needs in oncology, with an initial focus on hematology. The company's small molecule cancer therapeutics pipeline includes products designed to provide single agent efficacy and to enhance the efficacy of other anti-cancer therapies and regimens without overlapping toxicities.

© 2019 Canjex Publishing Ltd. All rights reserved.